Latest Neurodegeneration Stories
Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice.
McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson’s disease.
Scientists have identified a gene that keeps our nerve fibers from clogging up.
A protein known to be a key player in the development of Parkinson's disease is able to enter and harm cells in the same way that viruses do.
New research published Thursday in the journal Neuron sheds new light on the molecular causes of Alzheimer’s disease, while also revealing a potential new therapy which could help prevent cognitive decline and brain damage during the early stages of the neurodegenerative disorder.
Researchers have recently discovered that an expansion of DNA in patients with the common neurodegenerative disorder Fragile X-associated Tremor syndrome causes the production of an abnormal protein that is toxic to neurons.
The most common genetic cause of both ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) was recently identified as an alteration in the gene C9orf72.
New Market Research Report Added In MarketResearchReports.Biz Reports Database Neurodegenerative Diseases Market to 2018 - New Product Entries in Both Niche and Broader Parkinsons Disease Treatment
- The abrogation of a law by a higher authority; annulment.